NanoNIR Development of a fluorescence-based nanotool for early breast cancer diagnosis
- Coordinator
- Universitat Politecnica De Valencia, Spain
- Runs
- 1 September 2024 to 31 December 2027
- Status
- Running
- EU funding
- €201k
- Total cost
- —
- Partners
- 3 organisations in 2 countries
- Type
- Marie Skłodowska-Curie Action
- Grant agreement
- 101103902
What the project is doing
In the project's own words, from its summary on CORDIS.
Breast cancer is the most common cancer globally, accounting for 12% of all new annual cancer cases worldwide, according to the World Health Organization, and early detection is a key issue as survival improves when cancer is detected early. NanoNIR will develop a novel fluorescence-based nanotool for the detection and quantification of miR-99a-5p in liquid biopsy samples from breast cancer patients. The nanotool will consist of upconverting nanoparticles (UCNPs) decorated with aptamers and small gold nanoparticles (AuNPs).
UCNPs are inorganic nanocrystals that convert near-infrared (NIR) light into shorter wavelength emissions and exhibit narrow emission bandwidths and large anti-Stokes shifts (λex = 980 nm, λem = 540, 655 nm). These photophysical properties make them excellent candidates for fluorescence biosensing allowing for effective sensing with diminished background noise in a complicated detection system. The AuNPs have a large extinction coefficient and a broad UV–Vis absorption band (500 – 580 nm) making them excellent fluorescence quenching agents.
The combination of UCNPs (donors) with AuNPs (acceptors) linked through complementary aptamers will result in a fluorescence emission quenching of UCNPs at 540 nm. Following the detection of miR-99a-5p by its complementary aptamer sequence, AuNPs will be displaced from the UCNPs surface restoring the luminescence of UCNPs at 540 nm with an intensity-dependent to miRNA-9a-5p concentration allowing the detection of miR-99a-5p in real samples.
Additionally, the luminescence signal at 655 nm could be used for the ratiometric measurements.
Topics
Who is involved
| Organisation | City | Country | Role |
|---|---|---|---|
| Universitat Politecnica De Valencia | Valencia | Spain | Coordinator |
| Universitaet Regensburg | Regensburg | Germany | Associatedpartner |
| Fundacion Para La Investigacion Del Hospital Clinico De La Comunitat Valenciana, Fundacion Incliva | Valencia | Spain | Associatedpartner |
Source: CORDIS, European Commission. Data of 5 Nov 2026, reused under the Commission's reuse policy. View on CORDIS · Grant DOI